Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression

BACKGROUND: Brexanolone injection, the first therapy approved by the US FDA for the treatment of postpartum depression (PPD) in adults, has been shown to produce a significantly greater decrease in the Hamilton Rating Scale for Depression (HAM-D) total score than placebo in randomised controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Cooper, Miranda C., Kilvert, Hannah S., Hodgkins, Paul, Roskell, Neil S., Eldar-Lissai, Adi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825025/
https://www.ncbi.nlm.nih.gov/pubmed/31642037
http://dx.doi.org/10.1007/s40263-019-00672-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825025/
https://www.ncbi.nlm.nih.gov/pubmed/31642037
http://dx.doi.org/10.1007/s40263-019-00672-w

Ejemplares similares